Prof. Dr. YÜKSEL ÜRÜN

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Exploring the connection between microsatellite instability and inflammatory indicators in cancers

Karaoglan B. B., SAVAŞ B., Utkan G., Urun Y.

FUTURE ONCOLOGY , 2024 (SCI-Expanded)

The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study

GÜVEN D. C., Aykan M. B., MUĞLU H., BAYRAM E., Helvaci K., Dursun B., et al.

CANCER MEDICINE , cilt.13, sa.1, 2024 (SCI-Expanded)

Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study

Sekmek S., Karahan I., Ucar G., Ceylan F., Bayram D., Seven I., et al.

Clinical and Translational Oncology , 2024 (SCI-Expanded)

Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape

Ghose A., Lapitan P., Apte V., Ghosh A., Kandala A., Basu S., et al.

Current Oncology Reports , 2024 (SCI-Expanded)

Combination therapies in patients with favorable risk metastatic renal cell Carcinoma: A Systematic Review and Meta-Analysis

BÖLEK H., Yekedüz E., ÜRÜN Y.

Cancer Treatment Reviews , cilt.122, 2024 (SCI-Expanded)

Determining magnitude of benefit from poly(ADP-ribose) polymerase inhibitors in prostate cancer

AKBIYIK I., ÜRÜN Y.

FUTURE ONCOLOGY , sa.39, ss.2585-2591, 2023 (SCI-Expanded)

Adjuvant therapy for renal cell carcinoma: A systematic review of current landscape and future directions

BÖLEK H., ÜRÜN Y.

Critical Reviews in Oncology/Hematology , cilt.192, 2023 (SCI-Expanded)

Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients.

Eylemer Mocan E., Yekedüz E., Karataş G., Yazgan S. C., Köksoy E. B., Çay Şenler F., et al.

Anti-cancer drugs , 2023 (SCI-Expanded)

Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma

van der Heijden M. S., Sonpavde G., Powles T., Necchi A., Burotto M., Schenker M., et al.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.389, ss.1778-1789, 2023 (SCI-Expanded)

Cancer-associated thrombosis and drug-drug interactions of antithrombotic and antineoplastic agents

BÖLEK H., ÜRÜN Y.

CANCER , cilt.129, sa.20, ss.3216-3229, 2023 (SCI-Expanded)

The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study

Guven D. C., Yekeduz E., Erul E., YAZGAN S. C., Sahin T. K., KARATAŞ G., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.149, sa.7, ss.3599-3606, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer

Yekeduz E., McKay R. R., Gillessen S., Choueiri T. K., ÜRÜN Y.

ONCOLOGIST , sa.7, ss.596-603, 2023 (SCI-Expanded)

Five-Year Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice

Tural D., Arslan C., Selcukbiricik F., Olmez O. F., Akar E., ERMAN M., et al.

Clinical Genitourinary Cancer , cilt.21, sa.3, ss.334-341, 2023 (SCI-Expanded)

Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium

Erol C., Yekedüz E., Tural D., Karakaya S., Şentürk Öztaş N., Uçar G., et al.

Urologia Internationalis , cilt.107, sa.6, ss.595-601, 2023 (SCI-Expanded)

Awareness and perceptions of clinical trials in patients with cancer and their families in Turkey

Kubilay P., Erol C., Kahraman S., Tacar S. Y., Ozcan E., Basal F. B., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.41, sa.16, 2023 (SCI-Expanded)

Patient preferences for use of archived biospecimens in Turkey

Tolunay P. K., Erol C., Kahraman S., Tacar S. Y., Ozcan E., Basal F. B., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.41, sa.16, 2023 (SCI-Expanded)

Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

Gillessen S., Bossi A., Davis I. D., de Bono J., Fizazi K., James N. D., et al.

European Journal of Cancer , cilt.185, ss.178-215, 2023 (SCI-Expanded)

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

Gillessen S., Bossi A., Davis I. D., de Bono J., Fizazi K., James N. D., et al.

European Urology , cilt.83, sa.3, ss.267-293, 2023 (SCI-Expanded)

External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database

Yekedüz E., Karakaya S., Ertürk İ., Tural D., Uçar G., Şentürk Öztaş N., et al.

Clinical Genitourinary Cancer , cilt.21, sa.1, ss.175-182, 2023 (SCI-Expanded)

Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1, BRCA2, or ATM Alterations Identified by Testing Circulating Tumor DNA

Matsubara N., de Bono J., Olmos D., Procopio G., Kawakami S., ÜRÜN Y., et al.

Clinical cancer research : an official journal of the American Association for Cancer Research , cilt.29, sa.1, ss.92-99, 2023 (SCI-Expanded)

The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study

Yekeduz E., Tural D., Erturk I., Karakaya S., EROL C., Ercelep O., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.148, sa.12, ss.3537-3546, 2022 (SCI-Expanded)

Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitors

YAZGAN S. C., Yekeduz E., UTKAN G., ÜRÜN Y.

PROSTATE , cilt.82, sa.15, ss.1456-1461, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors

Yekeduz E., KÖKSOY E. B., YAZGAN S. C., KARATAŞ G., ÇAY ŞENLER F., UTKAN G., et al.

ANTI-CANCER DRUGS , cilt.33, sa.10, ss.1145-1149, 2022 (SCI-Expanded)

The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors

Yucel K. B., Yekeduz E., Karakaya S., Tural D., Erturk I., EROL C., et al.

SCIENTIFIC REPORTS , cilt.12, sa.1, 2022 (SCI-Expanded)

Significance of metabolic tumor volume and total lesion uptake measured using Ga-68 labelled prostate-specific membrane antigen PET/CT in primary staging of prostate cancer

KUBİLAY E., Akpinar C., OĞUZ E. S., ARAZ M., SOYDAL Ç., BALTACI S., et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , cilt.40, sa.9, 2022 (SCI-Expanded)

The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study

DOĞAN İ., Ayhan M., Gurbuz M., Kucukarda A., Aydın E., ÜRÜN Y., et al.

MEDICINE , cilt.101, sa.35, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib

Yekeduz E., Aktas E. G., KÖKSOY E. B., Dogan N., ÜRÜN Y., UTKAN G.

FUTURE ONCOLOGY , cilt.18, ss.1067-1076, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter study

Yekeduz E., Ozbay M. F., Caglayan D., Yildirim A., Erol C., Yildirim H. C., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.40, sa.4, 2022 (SCI-Expanded)

Long-term outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice.

Tural D., Arslan C., Selcukbiricik F., Olmez O. F., Erman M., Urun Y., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.40, sa.6, 2022 (SCI-Expanded)

Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors

Yekeduz E., UTKAN G., ÜRÜN Y.

FUTURE ONCOLOGY , cilt.18, ss.413-416, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer

Aydin S. G., Demirel B. C., Bilici A., Topcu A., Aykan M. B., Kahraman S., et al.

CURRENT MEDICAL RESEARCH AND OPINION , cilt.38, sa.10, ss.1751-1758, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database

Yekeduz E., Erturk I., Tural D., Karadurmus N., Karakaya S., Hizal M., et al.

FUTURE ONCOLOGY , cilt.17, ss.4861-4869, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study

Guven D. C., Acar R., Yekeduz E., Bilgetekin I., Baytemur N. K., EROL C., et al.

Current Problems in Cancer , cilt.45, 2021 (SCI-Expanded)

Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysis

Bakouny Z., Yekeduz E., Braun D. A., Berchuck J. E., Hirsch L., UTKAN G., et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.166, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors

Yekeduz E., Trapani D., Xu W., de Vries E. G. E., Labaki C., Gyawali B., et al.

INTERNATIONAL JOURNAL OF CANCER , cilt.149, sa.7, ss.1455-1462, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Treating relapsed and refractory metastatic germ cell tumours with high-dose chemotherapy with carboplatin and etoposide and autologous haematopoietic stem cell transplantation

Erturk I., Karadurmus N., Kiziloz H., Acar R., Yildiz B., Aykan M. B., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.7, ss.1657-1664, 2021 (SCI-Expanded)

Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (>= 75) patients

Alkan A., Guc Z. G., Gurbuz M., ozgun G., Degirmencioglu S., Dogan M., et al.

JOURNAL OF MENS HEALTH , cilt.17, sa.4, ss.128-134, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors

Yekeduz E., Ayasun R., KÖKSOY E. B., UTKAN G., ÜRÜN Y., AKBULUT H.

FUTURE VIROLOGY , cilt.16, sa.9, ss.583-585, 2021 (SCI-Expanded)

Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer

Soydal Ç., Araz M., Ürün Y., Nak D., Özkan E., Küçük N. Ö.

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.65, sa.3, ss.282-286, 2021 (SCI-Expanded)

Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences

Tural D., Ölmez Ö. F., Sümbül A. T., Artaç M., Özhan N., Akar E., et al.

European Urology Focus , cilt.7, sa.5, ss.1061-1066, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab

Tural D., Olmez O. F., Sumbul A. T., Ozhan N., ÇAKAR B., Kostek O., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , cilt.26, sa.8, ss.1506-1513, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Response to letter entitled: Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19

Yekeduz E., UTKAN G., ÜRÜN Y.

EUROPEAN JOURNAL OF CANCER , cilt.152, ss.248-249, 2021 (SCI-Expanded)

In the Age of Immunotherapy, How Can We Translate the CARMENA Results into Practice?

Yekeduz E., SÜER E., UTKAN G., BALTACI S., ÜRÜN Y.

EUROPEAN UROLOGY ONCOLOGY , cilt.4, sa.3, ss.515-516, 2021 (SCI-Expanded)

Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle?

Yekeduz E., UTKAN G., ÜRÜN Y.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.2, ss.450-452, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?

Yekeduz E., UTKAN G., Kanesvaran R., ÜRÜN Y.

PROSTATE INTERNATIONAL , cilt.9, sa.1, ss.1-5, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Olaparib efficacy in patients with metastatic castration-resistant prostate cancer (mCRPC) carrying circulating tumor (ct) DNA alterations in BRCA1, BRCA2 or ATM: Results from the PROfound study.

Matsubara N., De Bono J. S., Olmos D., Procopio G., Kawakami S., ÜRÜN Y., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.6, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Nivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.

Yekeduz E., Erturk I., Tural D., Karadurmus N., Karakaya S., Hizal M., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.6, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

ctDNA as a prognostic factor in operable colon cancer patients: a systematic review and meta-analysis

Yekeduz E., KÖKSOY E. B., AKBULUT H., ÜRÜN Y., UTKAN G.

FUTURE ONCOLOGY , cilt.17, sa.03, ss.349-357, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

A retrospective multicenter study: Clinicopathological factors affecting recurrence-free survival in operable gastric cancer patients.

Yekeduz E., Dogan I., AKBULUT H., Karabulut S., UTKAN G., ÜRÜN Y.

JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.3, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19

Yekeduz E., Utkan G., ÜRÜN Y.

EUROPEAN JOURNAL OF CANCER , cilt.141, ss.92-104, 2020 (SCI-Expanded)

Prevalence, etiology and risk factors of anemia in patients with newly diagnosed cancer

Kenar G., KÖKSOY E. B., ÜRÜN Y., UTKAN G.

SUPPORTIVE CARE IN CANCER , cilt.28, sa.11, ss.5235-5242, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Sweet's syndrome under ipilimumab therapy and a brief comparison of the cases in literature

Yasar H. A., AKKUŞ E., HEPER A., Akay B. N., ÜRÜN Y., UTKAN G.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.7, ss.1762-1764, 2020 (SCI-Expanded)

Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)

Hizal M., ŞENDUR M. A. N., Yasar H. A., Bir Yucel K., Arslan C., Ucar G., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.7, ss.1583-1589, 2020 (SCI-Expanded)

A clinical dilemma amid COVID-19 pandemic: missed or encountered diagnosis of cancer?

Yekeduz E., Karcioglu A. M., UTKAN G., ÜRÜN Y.

FUTURE ONCOLOGY , cilt.16, sa.25, ss.1879-1881, 2020 (SCI-Expanded)

The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer

Yasar H. A., Yucel K. B., Arslan C., Ucar G., Karakaya S., Bilgin B., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.5, ss.1110-1116, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab

Yekeduz E., DURSUN B., Aydin G., YAZGAN S. C., Ozturks H. H., AZAP A., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , sa.5, ss.1289-1294, 2020 (SCI-Expanded)

A systematic review: Role of systemic therapy on treatment and prevention of brain metastasis in renal cell carcinoma

Yekeduz E., Arzu Yasar H. A., UTKAN G., ÜRÜN Y.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.4, ss.972-981, 2020 (SCI-Expanded)

Predictor of Ga-68 PSMA PET/CT positivity in patients with prostate cancer

Soydal Ç., Ürün Y., Süer E., Nak D., Özkan E., Küçük N. Ö.

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.64, sa.2, ss.226-230, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study

Yasar H. A., Turna H., Esin E., Sedef A. M., Alkan A., Oksuzoglu B., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.2, ss.267-272, 2020 (SCI-Expanded)

Does primary tumor localization has prognostic importance in seminoma patients?: Turkish Oncology Group Study

Yildiz B., Kucukarda A., Gokyer A., Demiray A. G., PAYDAŞ S., Aral I. P., et al.

JOURNAL OF BUON , cilt.25, sa.2, ss.1130-1135, 2020 (SCI-Expanded)

Onco-cardiology: Drug-drug interactions of antineoplastic and cardiovascular drugs

Akbulut M., ÜRÜN Y.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.145, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Comparison of bone scintigraphy and Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography in the detection of bone metastases of prostate carcinoma

Soydal Ç., Nak D., Araz M., Akkus P., Ürün Y., Özkan E., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.40, sa.12, ss.1243-1249, 2019 (SCI-Expanded)

F-18-Flourodeoxy glucose PET-computed tomography in testicular carcinoma: diagnostic and prognostic value

Soydal Ç., Araz M., Ürün Y., Gülpınar B., Nak D., Özkan E., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.40, sa.12, ss.1268-1274, 2019 (SCI-Expanded)

Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?

ÜRÜN Y., Yasar H. A., TURNA Z. H., KILIÇKAP S., Sezer A., Oksuzoglu B., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.25, sa.8, ss.2062-2063, 2019 (SCI-Expanded)

Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study

ÜRÜN Y., Yasar H. A., TURNA Z. H., Esin E., Sedef A. M., Alkan A., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.25, sa.7, ss.1658-1664, 2019 (SCI-Expanded)

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes

Esin E., Oksuzoglu B., Bilici A., Cicin I., Kostek O., Kaplan M. A., et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , cilt.83, sa.1, ss.131-143, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

Merkel cell carcinoma in Turkey: A multicentric study.

Yildiz F., BÜYÜKŞİMŞEK M., Sakalar T., AYDIN ÜLGEN Ö., TURNA Z. H., Babacan N. A., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.36, sa.15, 2018 (SCI-Expanded)

Independent prognostic value of inflammation in metastatic pancreatic cancer.

Oksuzoglu B., Esin E., Koksoy E. B., Demirci N. S., Sendur M. A. N., Dede I., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.36, sa.15, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

Comparison of gemcitabine monotherapy with gemcitabine and cisplatin combination in metastatic pancreatic cancer: a retrospective analysis

Ergun Y., Ozdemir N. Y., Guner E. K., Esin E., ŞENDUR M. A. N., KÖKSOY E. B., et al.

JOURNAL OF BUON , cilt.23, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis

ÜRÜN Y., Leow J. J., Fay A. P., Albiges L., Choueiri T. K., Bellmunt J.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.120, ss.120-126, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

Relationship between metabolic parameters and ras mutation status

Karci E., SOYDAL Ç., Utkan G., ÜRÜN Y., Akbulut H.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.44, 2017 (SCI-Expanded)

Vaccination in oncology practice and predictors

Alkan A., Karci E., Yasar A., Tuncay G., KÖKSOY E. B., Urun M., et al.

SUPPORTIVE CARE IN CANCER , cilt.25, sa.9, ss.2677-2682, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients

Alkan A., Yasar A., Karci E., KÖKSOY E. B., Urun M., ÇAY ŞENLER F., et al.

SUPPORTIVE CARE IN CANCER , cilt.25, sa.1, ss.229-236, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

Benign metastasizing leiomyoma of bone and lung in postmenopausal women: two rare case reports and review of the literature

Cirak Y., Sever O. N., ÜRÜN Y.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , cilt.38, sa.1, ss.118-121, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma

de Velasco G., Gray K. P., Hamieh L., ÜRÜN Y., Carol H. A., Fay A. P., et al.

EUROPEAN UROLOGY FOCUS , cilt.2, sa.6, ss.633-639, 2016 (SCI-Expanded)

Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee of the Turkish Oncology Group (TOG)

Alkan A., Guc Z. G., ÇAY ŞENLER F., YAVUZŞEN T., Onur H., Dogan M., et al.

SUPPORTIVE CARE IN CANCER , cilt.24, sa.9, ss.3747-3755, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

ABO Blood Group Alleles and Prostate Cancer Risk: Results from the Breast and Prostate Cancer Cohort Consortium (BPC3)

Markt S. C., Shui I. M., Unger R. H., ÜRÜN Y., Berg C. D., Black A., et al.

PROSTATE , cilt.75, sa.15, ss.1677-1681, 2015 (SCI-Expanded)

The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer

ÜRÜN Y., UTKAN G., Yalcin B., AKBULUT H., Onur H., Oztuna D., et al.

Experimental Oncology , cilt.37, sa.1, ss.53-57, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials

Leow J. J., Martin-Doyle W., Rajagopal P. S., Patel C. G., Anderson E. M., Rothman A. T., et al.

EUROPEAN UROLOGY , cilt.66, sa.1, ss.42-54, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC)

Aizer A. A., ÜRÜN Y., McKay R. R., Kibel A. S., Nguyen P. L., Choueiri T. K.

BJU INTERNATIONAL , cilt.113, sa.5B, 2014 (SCI-Expanded)

Predictors of Outcome in Patients with Advanced Nonseminomatous Germ Cell Testicular Tumors

Yetisyigit T., Babacan N., ÜRÜN Y., Seber E. S., Cihan S., Arpaci E., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.2, ss.831-835, 2014 (SCI-Expanded)

Cetuximab Related Eyelash Elongations for Patients with Metastatic Rectum Carcinoma: Metabolic Complete Response

ÜRÜN Y., UTKAN G.

ANNALS OF DERMATOLOGY , cilt.25, sa.4, ss.504-505, 2013 (SCI-Expanded)

Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members

ÜRÜN Y., AKBULUT H., DEMİRKAZIK A., Senler F. C., Utkan G., Onur H., et al.

JOURNAL OF BUON , cilt.18, sa.2, ss.511-515, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Intraabdominal follicular dendritic cell sarcoma: A report of three cases and review of the literature

ÜRÜN Y., Kankaya D., Koral L., YALÇIN B., Karabork A., CEYHAN K., et al.

Tumori , cilt.99, sa.2, 2013 (SCI-Expanded)

Isolated Pulmonary Metastasis Presenting with an CEA Elevation Five Years After Radical Prostatectomy

ÜRÜN Y., UTKAN G., Percinel S., KAYI CANGIR A., Dogani M., Icli F.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.3, ss.200-201, 2013 (SCI-Expanded)

Clinicopathological Features of Patients with Malignant Mesothelioma in a Multicenter, Case-Control Study: No Role for ABO-Rh Blood Groups

UTKAN G., ÜRÜN Y., KAYI CANGIR A., Kilic D., Ozdemir N. Y., Oztuna D., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , sa.1, ss.249-253, 2013 (SCI-Expanded)

Association of ABO Blood Group and Risk of Lung Cancer in a Multicenter Study in Turkey

ÜRÜN Y., UTKAN G., KAYI CANGIR A., Oksuzoglu O. B., Ozdemir N., Oztuna D., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , sa.5, ss.2801-2803, 2013 (SCI-Expanded)

Solid pseudopapillary tumor of the pancreas: A case series of 7 patients

ÜRÜN Y., Kepenekci I., Tuzuner A., Dogan M., Erden E., Utkan G., et al.

Journal of B.U.ON. , cilt.17, sa.3, ss.600-601, 2012 (SCI-Expanded)

ABO and Rh blood groups frequency in women with HER2 positive breast cancer

ÜRÜN Y., Utkan G., Altundag K., Arslan O., Onur H., Arslan U. Y., et al.

JOURNAL OF BUON , cilt.17, sa.3, ss.457-460, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

Rituximab-related cryptogenic organizing pneumonia and late onset neutropenia in a patient with non-Hodgkin lymphoma: Report of two rare complications and review of the literature

ÜRÜN Y., Dincol D., ÖZDEMİR KUMBASAR Ö.

JOURNAL OF BUON , cilt.17, sa.3, ss.602-603, 2012 (SCI-Expanded)

Primary extranodal non-Hodgkin's lymphoma presenting as painful gingival swelling

ÜRÜN Y., Can F., BARIŞ E., AKBULUT H., UTKAN G., Içli F.

Experimental Oncology , cilt.34, sa.2, ss.134-135, 2012 (SCI-Expanded)

Lack of Any Relationship between ABO and Rh Blood Groups and Clinicopathological Features in Patients with Gastrointestinal Stromal Tumors: Turkish Oncology Group

ÜRÜN Y., Utkan G., YALÇIN Ş., COŞKUN H. Ş., Kocer M., Ozdemir N. Y., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , sa.8, ss.4129-4131, 2012 (SCI-Expanded)

ABO and Rh Blood Groups and Risk of Colorectal Adenocarcinoma

ÜRÜN Y., Ozdemir N. Y., UTKAN G., AKBULUT H., SAVAŞ B., Oksuzoglu B., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , sa.12, ss.6097-6100, 2012 (SCI-Expanded)

Kikuchi - Fujimoto disease: Cervical lymphadenopathy suggestive of relapsing lymphoma in patient with lymphoblastic lymphoma

ÜRÜN Y., UTKAN G., Kankaya D., DOĞAN M. K., YALÇIN B., Icli F.

Experimental Oncology , cilt.33, sa.4, ss.242-244, 2011 (SCI-Expanded)

Angiosarcoma related to immunosuppressive therapy 8 years after renal transplantation

ÜRÜN Y., DOĞAN İ., KİREMİTCİ S., AKBULUT H., Icli F.

ANNALS OF TRANSPLANTATION , cilt.16, sa.4, ss.138-140, 2011 (SCI-Expanded)

Two cases with atypical metastasis in colorectal cancer: Splenic and renal metastasis

DOĞAN M. K., Ozal G., Ekinci C., UTKAN G., ÜRÜN Y., Yalcin B., et al.

Experimental Oncology , cilt.32, sa.4, ss.277-279, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

How Shall We Name the Chemotherapy Administration Before and After Metastasectomy? How About "M-Neoadjuvant" and "M-Adjuvant"?

Abali H., Disel U., ÜRÜN Y., Gullu I., Saif M. W.

ANNALS OF SURGICAL ONCOLOGY , cilt.17, sa.7, ss.1970, 2010 (SCI-Expanded)

Silent Celiac Disease Presenting With Polyarthritis

Efe C., ÜRÜN Y., Purnak T., Ozaslan E., Ozbalkan Z., SAVAŞ B.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.16, sa.4, ss.195-196, 2010 (SCI-Expanded)

Activity of pemetrexed on brain metastases from non-small cell lung cancer: What is the mechanism?

Dogan M., Yalcin B., UTKAN G., ÜRÜN Y., Ozal G.

LUNG CANCER , cilt.66, sa.3, ss.399, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

Two cases with horseshoe kidney in association with nephrotic syndrome: Is there a causal relationship between two conditions?

Kayatas M., ÜRÜN Y.

RENAL FAILURE , cilt.29, sa.4, ss.517-518, 2007 (SCI-Expanded)

Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis

Sennaroglu E., Karakan S., Kayatas M., Akdur S., Genc H., Karakan T., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.51, sa.1, ss.121-122, 2006 (SCI-Expanded)

Performing only one cardiovascular reflex test has a high positive predictive value for diagnosing autonomic neuropathy in patients with chronic renal failure on hemodialysis

Sahin M., Kayatas M., ÜRÜN Y., Sennaroglu E., Akdur S.

RENAL FAILURE , cilt.28, sa.5, ss.383-387, 2006 (SCI-Expanded)

Bradycardia due to methylprednisolone therapy

Beyan E., ÜRÜN Y., Uzuner A.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.10, sa.4, ss.230, 2004 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler

Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study

AYDIN S., Kavak E. E., Topcu A., BAYRAMGİL A., Akgul F., Kahraman S., et al.

Biomolecules and Biomedicine , cilt.23, sa.6, ss.1089-1095, 2023 (Scopus)

Unresectable Hepatocellular Carcinoma and Prognostic Factors of Sorafenib Treatment: A Real-Life Experience

Erol C., Bardakçi M., Hizal M., Kahraman S., Yekedüz E., Güven D. C., et al.

Journal of Oncological Science , cilt.9, sa.2, ss.72-78, 2023 (Scopus)

Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study

Yekeduz E., DOĞAN İ., Kaya D. M., ÖZGÜR İ., UTKAN G., VATANSEVER S., et al.

JOURNAL OF GASTROINTESTINAL CANCER , cilt.53, sa.4, ss.870-879, 2022 (ESCI)

Management of metastatic castration-resistant prostate cancer in Middle East African countries: Challenges and strategic recommendations

Bazarbashi S., Alsharm A., Meshref A., Mrabti H., Ansari J., Ghosn M., et al.

UROLOGY ANNALS , cilt.14, sa.4, ss.303-313, 2022 (ESCI)

Predictive Factor for Lymph Node Metastasis in Non-Metastatic Colorectal Adenocarcinomas

Karcı E., Ürün Y., Köksoy E. B., Yekedüz E., Utkan G., Akbulut H., et al.

Eurasian Journal of Medical Investigation , cilt.6, sa.3, ss.279-283, 2022 (Hakemli Dergi)

Genomic Landscape of Actionable Mutations in Primary and Metastatic Tissues of Colon Adenocarcinoma

Yekeduz E., AKBULUT H., UTKAN G., ÜRÜN Y.

CUREUS JOURNAL OF MEDICAL SCIENCE , cilt.14, sa.4, 2022 (ESCI)

Sorafenib in Radioactive Iodine Refractory Differentiated Thyroid Cancer: A Real-life Data with Long-term Experience

Yekedüz E., Köksoy E. B., Şenler F., Akbulut H., Demirkazık A., Ürün Y., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.75, sa.1, ss.103-106, 2022 (Hakemli Dergi)

Adjuvant Treatment of Gastric Cancer in the D2 Dissection Era: A Real-life Experience from a Multicenter Retrospective Cohort Study.

YEKEDÜZ E., DOĞAN İ., DURU BİRGİ S., KESKİN M., KARAMAN Ş., UTKAN G., et al.

Euroasian journal of hepato-gastroenterology , cilt.11, sa.2, ss.51-58, 2021 (Hakemli Dergi)

Clinicopathological Characteristics and Oncological Outcomes of Non-urothelial Bladder Carcinomas: A Multicenter Study

Selvi I., Guven E. O., KÜTÜKOĞLU M. U., ÜRÜN Y., Tinay I.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.20, sa.2, ss.96-106, 2021 (ESCI) Sürdürülebilir Kalkınma

Changes in Metastatic Castration Sensitive Prostate Cancer

Gurbuz M., ÜRÜN Y.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.20, sa.1, ss.1-6, 2021 (ESCI)

Association between blood type and epidermal growth factor receptor mutation positivity in lung adenocarcinoma patients

Gürbüz M., AKKUŞ E., Karaalioğlu B., Aktaş E. G., KÖKSOY E. B., ÖZAKINCI H., et al.

Journal of Oncological Science , cilt.7, sa.1, ss.20-24, 2021 (Scopus)

Seasonal influenza and pneumococcal vaccination rates among patients with cancer in covid-19 pandemic: A cross-sectional study

Yekedüz E., KÖKSOY E. B., YAZGAN S. C., AKBIYIK I., BALLI S., Kavak E. E., et al.

Journal of Oncological Science , cilt.7, sa.2, ss.64-70, 2021 (Scopus)

Efficacy of Chemotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer Patients - Do Homologous Recombination Deficiency Affect the Outcomes?

Yekeduz E., UTKAN G., ÜRÜN Y.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.19, sa.4, ss.175-176, 2020 (ESCI) Sürdürülebilir Kalkınma

The Impact of Loneliness and Cancer Diagnosis on Cognitive Impairment in Geriatric Patients

ALKAN A., ÜRÜN Y., UTKAN G., AKBULUT H., TUNCAY G., ARAS S., et al.

Journal of Oncological Sciences , cilt.6, sa.2, ss.65-70, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma

The Impact of Loneliness and Cancer Diagnosis on Cognitive Impairment in Geriatric Patients.

ALKAN A., ÖZTORUN H. S., KARCI E., ÜRÜN Y., TUNCAY G., YAŞAR H. A., et al.

Journal of Oncological Sciences , cilt.6, sa.2, ss.65-70, 2020 (Hakemli Dergi)

Targeted Agents and Resistance Mechanism in Renal Cell Cancer

Rezapourbehnagh S., Yasar H. A., Arslan C., ÜRÜN Y.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.18, sa.2, ss.73-79, 2019 (ESCI) Sürdürülebilir Kalkınma

Nuclear Medicine Applications in Diagnosis of Urological Tumors

Araz M., Ürün Y.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.18, sa.2, ss.80-88, 2019 (ESCI)

Risk factors for thrombosis risk in patients with cancer

TURAN D., YAŞAR H. A., Aksu O. B., KÖKSOY E. B., UTKAN G., AKBULUT H., et al.

Journal of Oncological Sciences , cilt.4, sa.3, ss.130-133, 2018 (Hakemli Dergi) Sürdürülebilir Kalkınma

Osteonecrosis of the jaw with sunitinib and zoledronic acid combination: A case report

Tolunay P. K., YAŞAR H. A., UTKAN G., ÜRÜN Y.

Journal of Oncological Sciences , cilt.4, sa.2, ss.116-118, 2018 (Hakemli Dergi)

Positron Emission Tomography in Renal Cell Carcinoma

SOYDAL Ç., ÜRÜN Y.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.17, sa.2, ss.68-72, 2018 (ESCI)

Place in Concomitant Use with Anti-EGFR Radiotherapy in Locally Advanced Head and Neck Cancer Treatment

DAĞDELEN M., ÜRÜN Y.

MEANDROS MEDICAL AND DENTAL JOURNAL , cilt.19, sa.1, ss.95-98, 2018 (ESCI) Sürdürülebilir Kalkınma

Retrospective analysis of patients with relapsed or refractory germ cell tumors treated with autologous hematopoietic stem cell transplantation

Ertürk I., Yildiz B., Karadurmuş N., Tosun B., Esen R., Sürmeli Z. G., et al.

Gulhane Medical Journal , cilt.60, sa.4, ss.130-135, 2018 (Scopus)

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Evaluation of the success of 18F-PSMA PET/CT in the detection of prostate cancer recurrence in patients with biochemical recurrence

SÜTÇÜ G., SOYDAL Ç., ARAZ M., ÜRÜN Y., SÜER E., BALTACI S., et al.

Annual Congress of European Association of Nuclear Medicine, 9 - 13 Eylül 2023

PRe-treatment 68Ga-PSMA PET/CT parameters could predict response to 177Lu-PSMA tretament and overall survival in metastatic castration resistant prostate carcinoma patients treated with 177Lu-PSMA

ÖZKAN E., DEMİR B., ÖZTÜRK M., ARAZ M., SOYDAL Ç., DURSUN B., et al.

Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 Eylül 2023

Pre-treatment 68Ga-PSMA PEt/CT parameters could predict response to 177Lu-PSMA tdreatment and overall survival in metastatic castration resistant prostate carcinoma patients treated with 177Lu-PSMA

ÖZKAN E., DEMİR B., ÖZTÜRK M., ARAZ M., SOYDAL Ç., DURSUN B., et al.

Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 Eylül 2023

Evaluaion of the success of 18F-PSMA PET/CT in the detection odf prostate cencer recurrence in patients with biochemical recurrence

SÜTÇÜ G., SOYDAL Ç., ARAZ M., ÜRÜN Y., SÜER E., BALTACI S., et al.

Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 Eylül 2023

Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.

Tural D., Arslan C., Selcukbiricik F., Olmez O. F., Akar E., Erman M., et al.

Genitourinary Cancers Symposium, ELECTR NETWORK, 16 - 18 Şubat 2023

Construction of a New Model to Investigate Breast Cancer Data

Ağyüz U., PURUTÇUOĞLU GAZİ V., Purutçuoğlu E., ÜRÜN Y.

6th International Conference on Dynamics Games and Science, DGS-VI-2018, 19th Latin American Conference on Economic Theory, JOLATE 2018 and 21st International Consortium on Applied Bioeconomy Research, ICABR 2017, California, Amerika Birleşik Devletleri, 30 Mayıs - 02 Haziran 2017, cilt.365, ss.11-29

Erlotinib Kullanmakta Olan Bir Akciğer Adenokarsinoma Olgusunda Gelişen Skatrisyel Alopesi

ERTÜRK YILMAZ T., YILDIZHAN İ., HEPER A., ÜRÜN Y., İsmail Mendi B., BOYVAT A.

14. Ege Dermatoloji Günleri, Muğla/Bodrum, Türkiye, 1 - 05 Mayıs 2019

Plevral ve peritoneal iyi diferansiye papiller mezotelyoma olgusu

ÖZYURT N., YEKEDÜZ E., GÜRBÜZ M., YAŞAR H. A., KUBİLAY TOLUNAY P., KARAALİOĞLU B., et al.

23. Ulusal Kanser Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2019, ss.387

Comparison of bone sncitigraphy and Ga-68-PSMA PET/CT in the detection of bone metastases of prostate carcinoma

SOYDAL Ç., NAK D., ARAZ M., AKKUŞ P., ÜRÜN Y., ÖZKAN E., et al.

8th Balkan Congress Nuclear Medicine, 10 - 14 Nisan 2019

Prognostic importance of serum PSA response in patients who received Luttetium-177 prostate specific antigen treatment for castration resistant prostate cancer

SOYDAL Ç., ARAZ M., ÜRÜN Y., Nak D., ÖZKAN E., KÜÇÜK N. Ö.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45 Sürdürülebilir Kalkınma

MIDE KANSERI VE ABO KAN GRUBU İLIŞKISI: ÇOK MERKEZLI, GÖZLEMSEL, VAKA-KONTROL ÇALIŞMASI

YAŞAR H. A., UTKAN G., ÖZDEMİR N., ÇAKMAK ÖKSÜZOĞLU Ö. B., DEDE İ., ÜRÜN Y., et al.

7. Türk Tıbbı Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, ss.443

Efficiency and safety of regorafenib in metastatic colorectal cancer (mCRC): Real life experience from Turkey

Zengin G., Özyurt N., BEYPINAR İ., Çınkır H. Y., Bilgin B., GÜMÜŞAY Ö., et al.

ASCO 2018, 1 - 05 Haziran 2018, cilt.36, ss.15551 Sürdürülebilir Kalkınma

Merkel cell carcinoma in Turkey: A multicentric study.

yıldız f., BÜYÜKŞİMŞEK M., sakalar t., AYDIN Ö., TURNA Z. H., babacan n., et al.

2018 ASCO Annual Meeting, 1 - 05 Haziran 2018

TIROZIN KINAZ İNHIBITÖRÜ ILE TEDAVI EDILEN METASTATIK RENAL HÜCRELI KANSER OLGULARINDA SISTEMIK İMMÜN İNFLAMASYON İNDEKSININ TEDAVI YANITI ILE İLIŞKISI

BİR YÜCEL K., YAŞAR H. A., UÇAR G., UTKAN G., ÖZDEMİR N., ÜRÜN Y.

7. Türk Tıbbı Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, ss.177

SUNITINIB VE ZOLEDRONIK ASIT KULLANIMI İLE GELIŞEN ÇENE OSTEONEKROZU VAKASI

KUBİLAY TOLUNAY P., YAŞAR H. A., ÜRÜN Y., UTKAN G.

7. Türk Tıbbı Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, ss.287

NADIR BIR VAKA: SEFUROKSIM KULLANIMI SONRASINDA GELIŞEN RADYASYON RECALL DERMATITI

YAŞAR H. A., KUBİLAY TOLUNAY P., ÜRÜN Y., UTKAN G.

7. Türk Tıbbı Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, ss.282

SYSTEMIC IMMUNE INFLAMMATION INDEX AND TREATMENT RESPONSE IN PATIENTS WITH METASTATIC RENAL CELL CANCER

BİR YÜCEL K., YAŞAR H. A., UÇAR G., UTKAN G., ÖZDEMİR N., ÜRÜN Y.

2018 GENITOURINARY CANCERS SYMPOSIUM, SAN-FRANCISCO,CALIFORNIA, Amerika Birleşik Devletleri, 8 - 10 Şubat 2018, cilt.36, ss.591

Systemic immune inflammation index and treatment response in patients with metastatic renal cell cancer.

Yacel K. B., Yasar A., Ucar G., Utkan G., Yildirim N., ÜRÜN Y.

Genitourinary Cancers Symposium, San-Francisco, Kostarika, 8 - 10 Şubat 2018, cilt.36 Sürdürülebilir Kalkınma

Relationship between metabolic parameters and ras mutation status

KARCI E., SOYDAL Ç., UTKAN G., ÜRÜN Y., AKBULUT H.

30th Annual Congress of the European Association of Nuclear Medicine, 21 - 25 Ekim 2017, cilt.44, ss.696

Loneliness and cognitive dysfunction in elderly cancer patients

ALKAN A., SELVİ ÖZTORUN H., KARCI E., TUNCAY G., YAŞAR H. A., ÇINAR E., et al.

ESMO 2017, Madrid, İspanya, 12 - 16 Eylül 2017, ss.507-508 Sürdürülebilir Kalkınma

Loneliness and cognitive dysfunction in elderly cancer patients

Alkan A., Oztorun H. S., Karci E., Tuncay G., Yasar A., Cinar E., et al.

42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, İspanya, 8 - 12 Eylül 2017, cilt.28 Sürdürülebilir Kalkınma

Can serum prostat specific antigen levels be a predictor for 68Ga PSMA PET/CT positivity?

SOYDAL Ç., ÜRÜN Y., NAK D., ÖZKAN E., KÜÇÜK N. Ö.

SNMMI 2017 Annual Meeting, 22 - 26 Haziran 2017, cilt.58, ss.1078

Experience of 18F Flourodeoxy glucose (FDG) positron emission tomography (PET) - Computted tomography (CT) in testicular carcinoma

SOYDAL Ç., ÜRÜN Y., NAK D., ÖZKAN E., KÜÇÜK N. Ö.

SNMMI 2017 Annual Meeting, 22 - 26 Haziran 2017, cilt.58, ss.1069

Experience of 18F Flourodeoxy glucose (FDG) positron emission tomography (PET)-computed tomography (CT) in testicular carcinoma

SOYDAL Ç., ÜRÜN Y., NAK D., ÖZKAN E., KÜÇÜK N. Ö.

SNM Annual Meeting, Denver, Colorado, Amerika Birleşik Devletleri, 10 - 14 Haziran 2017, cilt.58, ss.1069

Can serum prostat specific antigen levels be a predictor for 68Ga PSMA PET/CT positivety?

SOYDAL Ç., ÜRÜN Y., SÜER E., NAK D., ÖZKAN E., KÜÇÜK N. Ö.

SNMMI 2017 Annual Meeting, Denver, Colorado, Amerika Birleşik Devletleri, 10 - 14 Haziran 2017, cilt.58, ss.1078

Asingle center analysis of evolving experience with ALPPS procedure: Towards better patient and graft selection

BALCI D., KIRIMKER E. O., ÖZÇELİK M., ÜSTÜNER E., KONCA C., UTKAN G., et al.

12th Biennial E-AHPBA Congress 2017, Mainz, Almanya, 23 - 26 Mayıs 2017

Experience of F-18 Flourodeoxy glucose (FDG) positron emission tomography (PET) -computed tomography (CT) in testicular carcinoma

SOYDAL Ç., ÜRÜN Y., Nak D., ÖZKAN E., KÜÇÜK N. Ö.

Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Colorado, Amerika Birleşik Devletleri, 10 - 14 Haziran 2017, cilt.58

Can serum prostat specific antigen levels be a predictor for Ga-68 PSMA PET/CT positivity?

SOYDAL Ç., ÜRÜN Y., SÜER E., Nak D., ÖZKAN E., KÜÇÜK N. Ö.

Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Colorado, Amerika Birleşik Devletleri, 10 - 14 Haziran 2017, cilt.58

Evre III Mide kanseri adjuvant tedavisinde dosetaksel- sisplatin- fluorourasil(DCF) rejiminin etkinliği

ALKAN A., Mızrak D., karcı E., YAŞAR H. A., KÖKSOY E. B., Ürün M., et al.

22. Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2017, ss.256-257

Kanser tanısı olan ve olmayan geriatrik hastalarda yalnızlık ve kognitif fonksiyonların değerlendirilmesi

ALKAN A., SELVİ ÖZTORUN H., karcı E., ÜRÜN Y., Tuncay G., YAŞAR H. A., et al.

22. Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2017, ss.247 Sürdürülebilir Kalkınma

KANSER TANISI OLAN VE OLMAYAN GERİATRİK HASTALARDA YALNIZLIK VE KOGNİTİF FONKSİYONLARIN DEĞERLENDİRİLMESİ

ALKAN A., SELVİ ÖZTORUN H., KARCI E., TUNCAY G., YAŞAR H. A., ÇINAR E., et al.

22. ULUSAL KANSER KONGRESİ, Türkiye, 19 - 23 Nisan 2017 Sürdürülebilir Kalkınma

TRPredictive factors of lymph node metastasis in patients with non metastatic colorectal Adenocarcinoma

Karcı E., KÖKSOY E. B., ALKAN A., Dede İ., Tuncay G., UTKAN G., et al.

ESMO Congress, 7 - 11 Ekim 2016

Vaccination in oncology practice and predictors

ALKAN A., KARCI E., YAŞAR H. A., TUNCAY G., ÜRÜN M., KÖKSOY E. B., et al.

ESMO, 7 - 10 Ekim 2016

Medical oncologists attitudes towards vaccination inoncology practice

ALKAN A., karcı e., YAŞAR H. A., tuncay g., ürün m., KÖKSOY E. B., et al.

ESMO annual meeting, 7 - 11 Ekim 2016

Predictive factors of lymph node metastasis in patients with non-metastatic colorectal adenocarcinoma

Karci E., Koksoy E. B., Alkan A., Dede I., Tuncay G., Utkan G., et al.

41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Danimarka, 7 - 11 Ekim 2016, cilt.27

Well differentiated papillary mesothelioma with peritoneal and pleural involvement Case report 8 11 September 2016 P Number 219

KAYI CANGIR A., SAKALLI M. A., YENİGÜN B. M., ÜRÜN Y., PERÇİNEL S.

26.th World Congress of Cardiothoracic Surgeon, Cape Town, South Africa, 8 - 11 Eylül 2016

Severe Drug Interactions and Potentially Inappropriate Medication Usage in Elderly Cancer Patients

ALKAN A., YAŞAR H. A., KARCI E., KÖKSOY E. B., ÜRÜN M., ÇAY ŞENLER F., et al.

ASCO, 6 - 10 Haziran 2016

Persistent postmastectomy pain syndrome and posttraumatic stress disorder among breast cancer survivors (ORTHUS study): A study of the palliative care working committee of the Turkish Oncology Group (TOG).

Alkan A., Guc Z. G., Senler F. C., YAVUZŞEN T., Onur H., Dogan M., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34

Severe drug interactions and potentially inappropriate medication usage in elderly patients with cancer.

Alkan A., Yasar A., Karci E., Koksoy E. B., Urun M., Senler F. C., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34

Geriatrik kanser hastalarında ciddi ilaç etkileşimi ve uygunsuz ilaç kullanımı

ALKAN A., YAŞAR H. A., KARCI E., KÖKSOY E. B., ürün m., ÇAY ŞENLER F., et al.

6.Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 23 - 27 Mart 2016, ss.167

Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study

ÜRÜN Y., Abali H., Turna H., Esin E., Sedef A. M., Alkan A., et al.

European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51

Can primary tumor localization predict the which patient will have benefit from addition of taxanes to platin-5-FU based regimens in metastatic gastric cancer. Multi center retrospective analysis from Turkey, Society of Turkish Oncology Group study

Kose F., Sedef A. M., Ozdemir N., Gunaldi M., ÜRÜN Y., Besen A. A., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33 Sürdürülebilir Kalkınma

Effect of metformin on sex steroid levels in postmenopausal type 2 diabetic patients

ÜNLÜTÜRK U., BAKAR F., ÜRÜN Y., NEBİOĞLU S., UYSAL A. R.

17th European Congress of Endocrinology, 16 - 20 Mayıs 2015, cilt.37

ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinium-based chemotherapy: A systematic review and meta-analysis.

ÜRÜN Y., Leow J. J., Fay A. P., Albiges L., Choueiri T. K., Bellmunt J.

Genitourinary Cancers Symposium, Florida, Amerika Birleşik Devletleri, 26 - 28 Şubat 2015, cilt.33 Sürdürülebilir Kalkınma

Predictors of outcome in patients with advanced nonseminamatous germ cell testicular tumors.

Yetisyigit T., Babacan N., ÜRÜN Y., Seber S., Arpaci E., Clhan S., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32

ABO blood group and risk of lethal prostate cancer

ÜRÜN Y., Wilson K. M., Shui I. M., Giovannucci E. L., Wolpin B. M., Nguyen P. L., et al.

Genitourinary Cancers Symposium, San-Francisco, Kostarika, 30 Ocak - 01 Şubat 2014, cilt.32 Sürdürülebilir Kalkınma

Role of cytoreductive nephrectomy (CN) in patients with metastatic non-clear cell renal cell carcinoma (nccRCC): results from a surveillance, epidemiology, and end results (SEER) database analysis of over 4,900 patients

Mckay R. R., Aizer A. A., ÜRÜN Y., Kibel A. S., Nguyen P. L., Choueiri T. K.

12th International Kidney Cancer Symposium, Illinois, Amerika Birleşik Devletleri, 25 - 26 Ekim 2013, cilt.112, ss.5-6

Pharmacogenetics as predictor of sunitinib and mTOR inhibitors toxicity in patients with metastatic renal cell carcinoma (mRCC)

ÜRÜN Y., Gray K. P., Signoretti S., McDermott D. F., Atkins M. B., Lampron M. E., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31

Serum CEA and CA 15-3 levels according to breast cancer subtypes

Dede I., Utkan G., AKBULUT H., ÜRÜN Y., Mizrak D., Icli F.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31 Sürdürülebilir Kalkınma

ABO blood group and the risk of lung cancer: Multicenter, case-control, observational study

Utkan G., ÜRÜN Y., Cangir A. K., Oksuzoglu O. B., Ozdemir N., Oztuna D., et al.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012

ABO blood group and the risk of breast cancer: Multicenter, case-control, observational study.

ÜRÜN Y., Koru-Sengul T., Altundag K., Utkan G., Onur H., AKBULUT H., et al.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30 Sürdürülebilir Kalkınma

The Significance of the Serum Leptin Ghreline Tumor Necrosis Factor Alpha and Interleukine 1 Levels in Patient With Non Small Cell Lung Cancer

ÜRÜN Y., YALÇIN B., KARATAŞ F., UTKAN G., YÜKSEL C., CANGIR A., et al.

The 2011 European Multidisiplinary Cancer Congress. Stockholm, Sweden, Stockholm, İsveç, 24 - 27 Eylül 2011, ss.612

The Significance of the Serum Leptin, Ghreline, Tumour Necrosis Factor Alpha and Interleukine-1 Levels in Patients With Non-Small Cell Lung Cancer

ÜRÜN Y., Yalcin B., Karatas F., Utkan G., YÜKSEL C., Cangir A., et al.

European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47 Sürdürülebilir Kalkınma

Status of Granulocyte Colony-Stimulating Factor Receptor in Tumour Tissue of Patients With Breast Cancer

Yalcin B., Gunaydin Y., Percinel S., Dogan M., ÜRÜN Y., Ozal F. G., et al.

ABO and Rh Blood Groups Frequency in Women With HER2(+) Breast Cancer

ÜRÜN Y., Utkan G., Altundag K., Arslan O., Onur H., Arslan U. Y., et al.

Relationship Between ABO and RH Blood Groups and K-Ras Phenotype in Patients With Colorectal Adenocarcinoma

ÜRÜN Y., Utkan G., Arslan O., AKBULUT H., Savas B., Senler F. C., et al.

European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47

Quality of Life Assesment in Patients With Non-Small Cell Lung Cancer Patients Who Have or Have Not Received Second Line Chemotherapy

Yalcin B., Suna N., Dogan M., ÜRÜN Y., Ozdemir N., Gonullu U., et al.

Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma

ÜRÜN Y., Abali H., Oksuzoglu B., Budakoglu B., Yildirim N., Guler T., et al.

49th Annual Meeting of the American-Society-of-Hematology, Georgia, Amerika Birleşik Devletleri, 8 - 11 Aralık 2007, cilt.110

Performing only 2 test have high sensitivity to diagnosis autonomic neuropathy in patients with chronic rena failure on hemodialysis

Sahin M., Kayatas M., Sennaroglu E., ÜRÜN Y., Akdur S.

42nd Annual Meeting of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA), İstanbul, Türkiye, 4 - 07 Haziran 2005, cilt.20